In this study, deficits in P300 amplitude appeared to precede psychosis onset. Target P3b amplitudes, in particular, may be sensitive to clinical outcomes in the PRS, including both conversion to psychosis and clinical remission. Auditory target P3b amplitude shows promise as a putative prognostic biomarker of clinical outcome in the PRS.
No takes yet. Share an insight, caveat, or question.
Hamilton et al. (2019) studied this question.
Synapse has enriched one closely related paper. Consider it for comparative context: